Ignite Creation Date:
2024-07-17 @ 11:13 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06483425
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-24
Brief Title:
A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer
Sponsor:
Tongji Hospital
Organization:
Tongji Hospital
Study Overview
Official Title:
A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial aims to investigate the role of biomarkers in guiding precision treatment for ovarian cancer The study will explore the effectiveness of personalized treatment strategies based on specific biomarkers identified in ovarian cancer patients By analyzing the correlation between biomarker profiles and treatment outcomes the trial seeks to optimize treatment decisions and improve overall survival rates in ovarian cancer patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None